What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
CIK: 0001535610
Total reported value
$110.5M
$110.5M
39 檔
28.8%
In Q3 2025, Sabby Management, LLC's U.S. equity holdings reached a combined market value of $110.5M, distributed across 39 disclosed stock positions.
Sabby Management, LLC executed strategic sector rebalancing during Q3 2025, establishing 31 new positions while fully exiting 38 holdings and trimming 6 positions.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ✓ | Ishares Tr | Stock-Other | 40.94% | +11.16% | -17.18% | |
| 2 | ✓ | Stock-Other | 19.30% | — | — | ||
| 3 | ✓ | Eos Energy Enterprises Inc | Stock-Other | 9.59% | — | -54.53% | |
| 4 | EMPD | Empery Digital Inc | Stock-Other | 4.07% | — | +1321.27% | |
| 5 | ✓ | Pop Culture Group Co LTD | Stock-Other | 2.63% | -2.25% | EXIT | |
| 6 | EVEX | Eve Holding Inc | Stock-Other | 2.13% | — | — | |
| 7 | ✓ | Can Fite Biofarma LTD | Stock-Other | 2.09% | — | +80.32% | |
| 8 | LYRA | Lyra Therapeutics Inc | Stock-Other | 2.00% | -0.57% | EXIT | |
| 9 | ✓ | Oceanpal Inc C | Stock-Other | 1.98% | — | — | |
| 10 | LMFA | Lm Funding America Inc | Stock-Other | 1.75% | — | — | |
| 11 | BIAF | Bioaffinity Technologies Inc | Stock-Other | 1.73% | +0.27% | NEW | |
| 12 | ✓ | Stock-Other | 1.17% | — | +3943.42% | ||
| 13 | INM | Inmed Pharmaceuticals Inc | Stock-Other | 1.16% | -1.53% | — | |
| 14 | ✓ | Epicquest Educatn Grp Intl L | Stock-Other | 0.96% | — | — | |
| 15 | SNES | Senestech Inc | Stock-Other | 0.75% | -3.82% | — | |
| 16 | ✓ | Geovax Labs Inc | Stock-Other | 0.75% | — | — | |
| 17 | ✓ | Zevra Therapeutics Inc | Stock-Other | 0.75% | -3.00% | +208.49% | |
| 18 | ✓ | Stock-Other | 0.71% | — | — | ||
| 19 | ✓ | Gevo Inc | Stock-Other | 0.66% | -16.06% | EXIT | |
| 20 | ✓ | Vision Marine Technologies I | Stock-Other | 0.61% | — | — | |
| 21 | ✓ | Core Scientific Inc New | Stock-Other | 0.56% | — | — | |
| 22 | ✓ | Stock-Other | 0.49% | — | — | ||
| 23 | ✓ | Ishares Tr | Stock-Other | 0.48% | +12.02% | NEW | |
| 24 | ✓ | Spdr S&P 500 Etf Tr Put Option | ETF-Large Cap & Growth | 0.41% | +45.73% | +39.25% | |
| 25 | ✓ | Stock-Other | 0.34% | — | — | ||
| 26 | BCTXZ | Briacell Therapeutics - 30 | Stock-Other | 0.30% | -0.31% | -37.45% | |
| 27 | NUWE | Nuwellis Inc | Stock-Other | 0.29% | — | — | |
| 28 | SNGX | Soligenix Inc | Stock-Other | 0.23% | — | — | |
| 29 | AIM | Aim Immunotech Inc | Stock-Other | 0.19% | — | — | |
| 30 | SPY | State Street SPDR S&P 500 ETF Trust | ETF-Large Cap & Growth | 0.19% | +13.85% | NEW | |
| 31 | OGEN | Oragenics Inc | Stock-Other | 0.19% | — | — | |
| 32 | TC | Token Cat LTD | Stock-Other | 0.13% | -2.71% | EXIT | |
| 33 | ✓ | Bluejay Diagnostics Inc | Stock-Other | 0.11% | — | -69.15% | |
| 34 | ✓ | Rubico Inc | Stock-Other | 0.11% | — | — | |
| 35 | ACXP | Acurx Pharmaceuticals Inc | Stock-Other | 0.09% | — | — | |
| 36 | ✓ | Bit Mining Limited | Stock-Other | 0.09% | — | — | |
| 37 | CORZ | Core Scientific Inc | Stock-Tech | 0.04% | — | — | |
| 38 | SLAI | Solai LTD | Stock-Other | 0.03% | — | — | |
| 39 | ✓ | Reviva Pharmaceutcls Hldgs Inc | Stock-Other | 0.02% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | ✓ | Spdr S&P 500 Etf Tr Put Option | +19.1% | +39.25% | Trim |
| 2 | ✓ | Ishares Tr | +18.5% | -17.18% | Trim |
| 3 | SPY | State Street SPDR S&P 500 ETF Trust | +9.1% | +18.00% | Add |
| 4 | ✓ | Eos Energy Enterprises Inc | +0.3% | -54.53% | Trim |
| 5 | ✓ | 0% | +3943.42% | Add | |
| 6 | ✓ | Zevra Therapeutics Inc | -0.7% | +208.49% | Trim |
| 7 | CORZ | Core Scientific Inc | -1.3% | — | Trim |
| 8 | ✓ | Reviva Pharmaceutcls Hldgs Inc | -11.9% | — | Trim |
| 9 | ✓ | Ishares Tr | — | NEW | New buy |
| 10 | ✓ | — | NEW | New buy | |
| 11 | SRFM | Surf Air Mobility Inc | — | EXIT | Sold out |
| 12 | IWM | Ishares Russell 2000 ETF | — | EXIT | Sold out |
| 13 | LLY | Eli Lilly & Co | — | EXIT | Sold out |
| 14 | EOSE | Eos Energy Enterprises Inc | — | EXIT | Sold out |
| 15 | EMPD | Empery Digital Inc | — | NEW | New buy |
| 16 | ✓ | Eli Lilly & Co | — | EXIT | Sold out |
| 17 | ✓ | Bit Digital Inc | — | EXIT | Sold out |
| 18 | KSCP | Knightscope Inc-a | — | EXIT | Sold out |
| 19 | ✓ | Pop Culture Group Co LTD | — | NEW | New buy |
| 20 | ✓ | Bit Digital Inc | — | EXIT | Sold out |
| 21 | VANI | Vivani Medical Inc | — | EXIT | Sold out |
| 22 | EVEX | Eve Holding Inc | — | NEW | New buy |
| 23 | ✓ | Can Fite Biofarma LTD | — | NEW | New buy |
| 24 | LYRA | Lyra Therapeutics Inc | — | NEW | New buy |
| 25 | ✓ | Oceanpal Inc C | — | NEW | New buy |
| 26 | ACXPEUR | Acurx Pharmaceuticals Inc | — | EXIT | Sold out |
| 27 | LMFA | Lm Funding America Inc | — | NEW | New buy |
| 28 | CYN | Cyngn Inc | — | EXIT | Sold out |
| 29 | BIAF | Bioaffinity Technologies Inc | — | NEW | New buy |
| 30 | SPY | Ss Spdr S&p 500 ETF Trust-us | — | EXIT | Sold out |
| 31 | ✓ | Eli Lilly & Co | — | EXIT | Sold out |
| 32 | INM | Inmed Pharmaceuticals Inc | — | NEW | New buy |
| 33 | ✓ | Epicquest Educatn Grp Intl L | — | NEW | New buy |
| 34 | HEPA | Hepion Pharmaceuticals Inc | — | EXIT | Sold out |
| 35 | ✓ | Sharps Technology Inc | — | EXIT | Sold out |
| 36 | XTIA | Xti Aerospace Inc | — | EXIT | Sold out |
| 37 | SNES | Senestech Inc | — | NEW | New buy |
| 38 | ✓ | Geovax Labs Inc | — | NEW | New buy |
| 39 | ✓ | — | NEW | New buy | |
| 40 | ✓ | Wang Lee Group Inc | — | EXIT | Sold out |
| 41 | ✓ | Gevo Inc | — | NEW | New buy |
| 42 | AEON | Aeon Biopharma Inc | — | EXIT | Sold out |
| 43 | ✓ | Vision Marine Technologies I | — | NEW | New buy |
| 44 | ✓ | Core Scientific Inc New | — | NEW | New buy |
| 45 | ✓ | Snow Lake Res LTD | — | EXIT | Sold out |
| 46 | ✓ | — | NEW | New buy | |
| 47 | ✓ | Volcon Inc | — | EXIT | Sold out |
| 48 | ✓ | — | EXIT | Sold out | |
| 49 | ✓ | Psyence Biomedical LTD Com New | — | EXIT | Sold out |
| 50 | HUSAUSD | Houston American Energy CORP | — | EXIT | Sold out |
According to official SEC Form 13F filings, Sabby Management, LLC reported a total U.S. public equity portfolio value of $110.5M across 39 disclosed positions in Q3 2025.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including ISHARES TR, , EOS ENERGY ENTERPRISES INC) accounted for 28.8% of total reported equity market value during Q3 2025.
Top New Position Initiated
ISHARES TR
市值: $20.2M
Top Position Liquidated / Trimmed
SRFM
前期市值: $4.7M
During Q3 2025, Sabby Management, LLC's top holdings by market value included ISHARES TR (40.9%)、 (19.3%)、EOS ENERGY ENTERPRISES INC (9.6%). The largest single position, ISHARES TR, represented 40.9% of total portfolio value.
In Q3 2025, Sabby Management, LLC made 77 total portfolio adjustments, initiating 31 new buys, adding to 2 positions, trimming 6 holdings, and fully liquidating 38 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.